Search

everythinglearnresearchcommunity

for

Search:↓

AGA affects many, progresses differently, and early treatment is crucial.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

CT scans can find serious prostate cancer even when PSA levels are low.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Using finasteride with TIP extends time off period for prostate cancer patients.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

Suppressing certain hormones might help prevent prostate cancer.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Male pattern baldness does not cause an increased risk of prostate cancer.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Balding and low testosterone increase risk of urinary stones.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.